BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 18191528)

  • 1. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
    Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
    Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
    J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
    Huguet F; André T; Hammel P; Artru P; Balosso J; Selle F; Deniaud-Alexandre E; Ruszniewski P; Touboul E; Labianca R; de Gramont A; Louvet C
    J Clin Oncol; 2007 Jan; 25(3):326-31. PubMed ID: 17235048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma.
    Moutardier V; Magnin V; Turrini O; Viret F; Hennekinne-Mucci S; Gonçalves A; Pesenti C; Guiramand J; Lelong B; Giovannini M; Monges G; Houvenaeghel G; Delpero JR
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):437-43. PubMed ID: 15380577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
    White RR; Kattan MW; Haney JC; Clary BM; Pappas TN; Tyler DS; Brennan MF
    Ann Surg Oncol; 2006 Nov; 13(11):1485-92. PubMed ID: 17013688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.
    Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; de Chaisemartin C; Giovannini M; Delpero JR
    Oncology; 2009; 76(6):413-9. PubMed ID: 19407474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second-look operation in pancreatic carcinoma previously assessed as unresectable].
    Warnick P; Bahra M; Andreou A; Neuhaus P; Glanemann M
    Zentralbl Chir; 2010 Feb; 135(1):70-4. PubMed ID: 20162503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A modified Dworak classification applied to pancreatic adenocarcinoma: a useful prognostic factor].
    Turrini O; Viret F; Moureau L; Guiramand J; Lelong B; Bège T; Giovannini M; Delpero JR
    Bull Cancer; 2007 Oct; 94(10):897-901. PubMed ID: 17964983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
    Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
    World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic hepatic irradiation following curative resection of pancreatic cancer.
    Hishinuma S; Ogata Y; Tomikawa M; Ozawa I; Inoue K; Katano S; Tsukiyama I
    J Hepatobiliary Pancreat Surg; 2005; 12(3):235-42. PubMed ID: 15995813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.
    Chao C; Hoffman JP; Ross EA; Torosian MH; Eisenberg BL
    Am Surg; 2000 Apr; 66(4):378-85; discussion 386. PubMed ID: 10776876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival (superior to 20 years) after pancreaticoduodenectomy for pancreatic duct adenocarcinoma: report of two cases.
    Naseef O; Adham M; Hervieu V; Le Borgne J; Partensky C
    Hepatogastroenterology; 2008; 55(84):1110-1. PubMed ID: 18705340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
    White RR; Tyler DS
    Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
    Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
    Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
    Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
    Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.